title: The effect of ST2 gene product on anchorage-independent growth of a glioblastoma cell line, T98G.
abstract: The ST2 gene, which is specifically induced by growth stimulation in fibroblasts, encodes interleukin-1 receptor-related proteins and is widely expressed in hematopoietic, helper T, and various cancer cells. However, the physiological as well as pathological functions of the ST2 gene products are not yet fully understood. In this study, we analyzed the expression of the ST2 gene in human glioma cell lines and human brain tumor samples with real-time polymerase chain reaction method, the results of which revealed that the expression level of the ST2 gene in glioma cell lines and glioblastoma samples is significantly lower than that in a fibroblastic cell line, TM12, and benign brain tumors, suggesting the reverse relationship between malignancy and ST2 expression. As we could not detect the soluble ST2 protein in the culture fluid of the T98G glioblastic cell line by ELISA, we established stable transformants of T98G that continuously produce and secrete the ST2 protein, in order to study the effect of the ST2 protein on malignancy. Although we could not detect a remarkable difference in proliferation between transformants and control cells in conventional tissue culture dishes, the efficiency of colony formation in soft agar was significantly decreased in the case of cells that continuously produce the ST2 protein. Furthermore, inhibition of colony formation in soft agar was observed in wild-type T98G cells when purified soluble ST2 protein was added to the culture, in a dose-dependent manner. Taken together, the results suggest that the expression of ST2 suppressed the anchorage-independent growth and malignancy.
authors.affiliation: Department of Surgical Neurology and Department of Biochemistry, Jichi Medical School, Minamikawachi-machi, Kawachi-gun, Tochigi, Japan.
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Haga
authors.forename: Ken
authors.initials: K
authors.lastname: Yanagisawa
authors.forename: Hiromi
authors.initials: H
authors.lastname: Ohto-Ozaki
authors.forename: Shin-Ichi
authors.initials: S
authors.lastname: Tominaga
authors.forename: Toshio
authors.initials: T
authors.lastname: Masuzawa
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Iwahana
mesh_terms: D001932:Brain Neoplasms / Q000235:genetics; D002455:Cell Division / Q000235:genetics; D016543:Central Nervous System Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology*; D005909:Glioblastoma / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology*; D006801:Humans; D000072179:Interleukin-1 Receptor-Like 1 Protein; D008565:Membrane Proteins / Q000235:genetics* / Q000378:metabolism / Q000494:pharmacology; D011401:Promoter Regions, Genetic; D011956:Receptors, Cell Surface; D014407:Tumor Cells, Cultured; D014410:Tumor Stem Cell Assay
chemical_list: C079241:IL1RL1 protein, human; D000072179:Interleukin-1 Receptor-Like 1 Protein; D008565:Membrane Proteins; D011956:Receptors, Cell Surface